2004
DOI: 10.1080/j.0001-6349.2004.00217.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2006
2006
2011
2011

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 0 publications
1
2
0
Order By: Relevance
“…The changes in lipid/lipoproteins following therapy with CE/MPA in our study population are consistent with those found in Western women 47 and those reported for Chinese women in Taiwan 48 and Hong Kong 49 . These responses include lipid/lipoprotein changes that have traditionally been considered cardioprotective 50 , a conclusion that has been questioned after the publication of the Women's Health Initiative (WHI) study 51 and two secondary prevention studies 52,53 .…”
Section: Discussionsupporting
confidence: 92%
“…The changes in lipid/lipoproteins following therapy with CE/MPA in our study population are consistent with those found in Western women 47 and those reported for Chinese women in Taiwan 48 and Hong Kong 49 . These responses include lipid/lipoprotein changes that have traditionally been considered cardioprotective 50 , a conclusion that has been questioned after the publication of the Women's Health Initiative (WHI) study 51 and two secondary prevention studies 52,53 .…”
Section: Discussionsupporting
confidence: 92%
“…LDL is one of the lipoproteins that promote endothelial damage, as well as reduction of high-density lipoprotein (HDL), a pleiotropic lipoprotein that prevents or alleviates endothelial damage (2). Studies have shown that estrogen replacement therapy and estrogen plus progestin replacement therapy alter these levels by decreasing LDL cholesterol levels and increasing HDL cholesterol levels (3,4). However, HDL cholesterol levels in women vary considerably in response to hormone replacement therapy (HRT) and a significant portion of the variability in HDL cholesterol levels can be attributed to genetic factors (5)(6)(7).…”
Section: Introductionmentioning
confidence: 99%
“…Estrogen exerts beneficial effects on blood lipids, lowdensity lipoprotein (LDL)/high-density lipoprotein (HDL) ratio, plasma triacylglycerol, and vascular function. [1][2][3][4] Recently, the cardiovascular benefits of hormone replacement therapy have been questioned, [5][6][7][8] and such therapy is no longer considered a viable option for reducing CVD in postmenopausal women. Therefore, other means of modulating cholesterol and reducing the risk of CVD in the absence of estrogen are desirable.…”
Section: Introductionmentioning
confidence: 99%